Alnylam Pharmaceuticals (ALNY) Inventory (2018 - 2026)

Alnylam Pharmaceuticals' Inventory history runs 9 years deep, the most recent figure standing at $84.0 million for Q1 2026.

• Quarterly Inventory rose 28.12% year-over-year to $84.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.0 million (up 28.12% YoY) and the FY2025 annual result came in at $82.7 million, up 5.36% from the prior year.
• Inventory was $84.0 million for Q1 2026 at Alnylam Pharmaceuticals, up from $82.7 million in the prior quarter.
• Across five years, Inventory topped out at $131.9 million in Q1 2023 and bottomed at $65.6 million in Q1 2025.
• A 5-year average of $90.7 million and a median of $84.0 million in 2026 frame the typical range for Inventory.
• Peak annual rise in Inventory reached 67.96% in 2023, while the deepest fall reached 30.87% in 2023.
• Alnylam Pharmaceuticals' Inventory stood at $129.0 million in 2022, then tumbled by 30.87% to $89.1 million in 2023, then dropped by 11.93% to $78.5 million in 2024, then gained by 5.36% to $82.7 million in 2025, then increased by 1.58% to $84.0 million in 2026.
• Business Quant data shows ALNY's Inventory at $84.0 million in Q1 2026, $82.7 million in Q4 2025, and $75.4 million in Q3 2025.